Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - NET CHANGE IN CASH
Net Change in Cash REGN - Regeneron Pharmaceuticals, Inc.
-249 M
LAST VALUE
-45.75%
2 YEAR CAGR
-21.59%
5 YEAR CAGR
-12.33%
10 YEAR CAGR